Press Releases

All Releases
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
Sep 21, 2016
ALBANY, N.Y. , Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
Sep 06, 2016
ALBANY, N.Y. , Sept. 06, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference
Aug 08, 2016
ALBANY, N.Y. , Aug. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
Aug 01, 2016
ALBANY, N.Y. , Aug. 01, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Avista Capital Partners, LP and affiliated investment
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters
Jul 27, 2016
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters   ALBANY, N.Y., July 27, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, issued
AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
Jul 25, 2016

Greiner brings more than 20 years of accounting, corporate finance and operations experience from a variety of global corporations

AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
Jul 13, 2016
Q4 Net sales of $93.4 million , up 3% year-over-year Q4 GAAP loss per share of $1.21 , inclusive of a one-time tax asset write down of $40.1 million ; Non-GAAP adjusted EPS of $0.19 , up 37% year-over-year Q4 Operating cash generation of $18.5 million FY2017 revenue guidance set at $355-$360
AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results
Jun 29, 2016
ALBANY, N.Y. , June 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 fourth
AngioDynamics Reports Fiscal 2016 Third Quarter Results
Apr 07, 2016
Net sales of $87.4 million , up 1% year-over-year GAAP earnings per share of $0.02 ; Non-GAAP adjusted EPS of $0.15 , up 25% year-over-year Operating cash generation of $12.4 million FY2016 financial guidance updated   ALBANY, N.Y. , April 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a
AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
Apr 04, 2016

Clemmer brings more than 25 years of operational, manufacturing, marketing and business development experience in the global healthcare industry

AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
Mar 29, 2016
ALBANY, N.Y. , March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third
AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
Mar 10, 2016
ALBANY, N.Y. , March 10, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that they have signed an agreement with Merz North America ,
AngioDynamics to Present at the Barclays Global Healthcare Conference
Mar 07, 2016
ALBANY, N.Y. , March 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada
Feb 08, 2016
ALBANY, N.Y. , Feb. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Celerity PICC Tip Confirmation System with Navigation has
AngioDynamics Reports Fiscal 2016 Second Quarter Results
Jan 07, 2016
Net sales of $89.2 million GAAP loss of $0.01 per share; Non-GAAP adjusted EPS of $0.14 Operating cash generation of $9.6 million ALBANY, N.Y. , Jan. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,
AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference
Jan 04, 2016
ALBANY, N.Y. , Jan. 04, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph DeVivo , President and Chief Executive Officer, is
AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results
Dec 28, 2015
ALBANY, N.Y. , Dec. 28, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 second
FDA Lifts Warning Letters on AngioDynamics' Facilities
Dec 03, 2015

Completes Resolution of All Outstanding Warning Letters

AngioDynamics to Present at the Piper Jaffray 27th Annual Healthcare Conference
Nov 23, 2015
ALBANY, N.Y. , Nov. 23, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics Announces Resolution of FDA Warning Letter
Nov 17, 2015
ALBANY, N.Y. , Nov. 17, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announces that it has received a letter from the United Stated Food and Drug
Displaying 41 - 60 of 617

Copyright Nasdaq. Minimum 15 minutes delayed.